SARS-CoV-2 vaccines: fast track versus efficacy

Dana Alkandari; Jenny A Herbert; Moustafa A Alkhalaf; Carol Yates; Stavros Panagiotou

doi:10.1016/S2666-5247(21)00034-3

SARS-CoV-2 vaccines: fast track versus efficacy

Dana Alkandari, Jenny A Herbert, Moustafa A Alkhalaf, Carol Yates, Stavros Panagiotou

Medical Education (L5)

University of Manchester

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e89-e90
Journal	The Lancet. Microbe
Volume	2
Issue number	3
DOIs	https://doi.org/10.1016/S2666-5247(21)00034-3
Publication status	Published - Mar 2021

Keywords

COVID-19/prevention & control
COVID-19 Vaccines/therapeutic use
Humans
SARS-CoV-2
Vaccines, DNA

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2666-5247(21)00034-3

Cite this

@article{6123f9932e464d0ea987e40cf47b01b1,

title = "SARS-CoV-2 vaccines: fast track versus efficacy",

keywords = "COVID-19/prevention & control, COVID-19 Vaccines/therapeutic use, Humans, SARS-CoV-2, Vaccines, DNA",

author = "Dana Alkandari and Herbert, {Jenny A} and Alkhalaf, {Moustafa A} and Carol Yates and Stavros Panagiotou",

year = "2021",

month = mar,

doi = "10.1016/S2666-5247(21)00034-3",

language = "English",

volume = "2",

pages = "e89--e90",

journal = "The Lancet. Microbe",

issn = "2666-5247",

publisher = "The Lancet",

number = "3",

}

TY - JOUR

T1 - SARS-CoV-2 vaccines

T2 - fast track versus efficacy

AU - Alkandari, Dana

AU - Herbert, Jenny A

AU - Alkhalaf, Moustafa A

AU - Yates, Carol

AU - Panagiotou, Stavros

PY - 2021/3

Y1 - 2021/3

KW - COVID-19/prevention & control

KW - COVID-19 Vaccines/therapeutic use

KW - Humans

KW - SARS-CoV-2

KW - Vaccines, DNA

U2 - 10.1016/S2666-5247(21)00034-3

DO - 10.1016/S2666-5247(21)00034-3

M3 - Article

C2 - 33659918

SN - 2666-5247

VL - 2

SP - e89-e90

JO - The Lancet. Microbe

JF - The Lancet. Microbe

IS - 3

ER -